KMT2C and metastatic neoplasm: To gain insight into the mutational spectrum of human PCa we analysed a cohort of 1013 patients with either localized or metastatic disease (MSKCC/DFCI cohort) [15] and found KMT2C to be the 7th most frequently mutated gene (Fig. 1b, left panel).